Silvant Capital Management’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,715
| Closed | -$701K | – | 339 |
|
|
2022
Q1 | $701K | Sell |
9,715
-119
| -1% | -$8.59K | 0.13% | 103 |
|
|
2021
Q4 | $903K | Sell |
9,834
-434
| -4% | -$39.9K | 0.15% | 98 |
|
|
2021
Q3 | $1.3M | Sell |
10,268
-2,038
| -17% | -$258K | 0.23% | 82 |
|
|
2021
Q2 | $2.05M | Sell |
12,306
-210
| -2% | -$34.9K | 0.32% | 76 |
|
|
2021
Q1 | $2.28M | Sell |
12,516
-343
| -3% | -$62.3K | 0.39% | 67 |
|
|
2020
Q4 | $2.57M | Sell |
12,859
-233
| -2% | -$46.6K | 0.44% | 61 |
|
|
2020
Q3 | $2.87M | Buy |
13,092
+2,445
| +23% | +$536K | 0.54% | 48 |
|
|
2020
Q2 | $2.03M | Sell |
10,647
-690
| -6% | -$132K | 0.37% | 75 |
|
|
2020
Q1 | $1.76M | Sell |
11,337
-213
| -2% | -$33K | 0.38% | 72 |
|
|
2019
Q4 | $967K | Buy |
+11,550
| New | +$967K | 0.18% | 98 |
|